Aster DM Quality Care Q1 Profit Falls 81% to ₹16 Crore

Aster DM Quality Care reported a consolidated net profit of ₹16.1 crore for the quarter ended June 2026, down 81.2% from ₹85.5 crore in the corresponding period last year.

The decline in profitability came despite healthy growth in patient volumes and improved operational efficiency across its hospital network. Revenue from operations rose 21.6% year-on-year to ₹1,311 crore during the quarter, compared with ₹1,078 crore a year ago.

The growth was driven by higher patient footfalls and stronger performance across both mature and emerging hospitals. At the operating level, earnings before interest, tax, depreciation and amortisation (EBITDA) increased 27.5% to ₹264.3 crore from ₹207.4 crore in the year-ago period.

EBITDA margin improved to 20.2% from 19.2%, as per the filing. The company said total patient volumes grew 16% year-on-year during the quarter. Revenue from mature hospitals rose 19%, while emerging hospitals recorded a sharp 95% increase in revenue, supported by rising utilisation levels and expanding healthcare demand.

Managing Director and Group CEO Varun Khanna commented on the results, saying the merger and formation of Aster DM Quality Care marked a significant milestone for the company. On a combined pro forma basis, the merged entity reported revenue of ₹2,597 crore during the quarter, up 20% year-on-year.

Operating EBITDA rose 30% to ₹576 crore, while EBITDA margin expanded by 170 basis points to 22.2%. Khanna said the combined platform served nearly 2 million outpatient and inpatient visits during the quarter, representing a 13% increase from the year-ago period.

The company's focus will remain on integrating operations, improving efficiencies and strengthening patient care delivery across its expanded healthcare network. Shares of Aster DM Quality Care ended 0.2% lower at ₹833 ahead of the earnings announcement.

Aster DM Quality Care's performance is significant for the healthcare sector, which has seen growth in recent years. The company's merger and integration efforts are expected to drive future growth.

The decline in profit despite revenue growth may be a concern for investors, but the company's focus on integration and efficiency improvement is expected to yield positive results in the long term.

Overall, Aster DM Quality Care's Q1 results reflect the challenges and opportunities in the healthcare sector, and the company's efforts to navigate these challenges will be closely watched by investors and industry observers.

The company's performance has implications for the broader healthcare industry, and its focus on integration and efficiency improvement may set a precedent for other healthcare providers.

In conclusion, Aster DM Quality Care's Q1 results are a mixed bag, with revenue growth and declining profitability. The company's focus on integration and efficiency improvement is expected to drive future growth, and its performance will be closely watched by investors and industry observers.